Aliases & Classifications for Bd Syndrome

MalaCards integrated aliases for Bd Syndrome:

Name: Bd Syndrome 50

Classifications:



Summaries for Bd Syndrome

MalaCards based summary : Bd Syndrome is related to intellectual disability - athetosis - microphthalmia and cerebral palsy. The drugs Ticagrelor and Ticlopidine have been mentioned in the context of this disorder. Affiliated tissues include endothelial, liver and heart.

Related Diseases for Bd Syndrome

Diseases related to Bd Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 intellectual disability - athetosis - microphthalmia 10.8
2 cerebral palsy 9.7
3 cerebritis 9.7

Symptoms & Phenotypes for Bd Syndrome

Drugs & Therapeutics for Bd Syndrome

Drugs for Bd Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 157)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ticagrelor Approved Phase 4,Phase 3 274693-27-5 9871419
2
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
3
Metformin Approved Phase 4,Early Phase 1 657-24-9 14219 4091
4
Alverine Approved Phase 4 150-59-4 3678
5
Nitric Oxide Approved Phase 4 10102-43-9 145068
6
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 1 134678-17-4 60825
7
Everolimus Approved Phase 4 159351-69-6 6442177
8
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
9
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
10
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
11
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
12
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
13
Mycophenolate mofetil Approved, Investigational Phase 4 128794-94-5 5281078
14
Mycophenolic acid Approved Phase 4 24280-93-1 446541
15
Allopurinol Approved Phase 4 315-30-0 2094
16
Clopidogrel Approved, Nutraceutical Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
17
Mebeverine Investigational Phase 4 3625-06-7 62887
18 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
19 Fibrinolytic Agents Phase 4,Phase 3
20 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
21 Platelet Aggregation Inhibitors Phase 4,Phase 3
22 Purinergic P2 Receptor Antagonists Phase 4,Phase 3
23 Purinergic P2Y Receptor Antagonists Phase 4,Phase 3
24 Vasodilator Agents Phase 4,Phase 3,Phase 2
25 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
26 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Immunosuppressive Agents Phase 4,Phase 2
28 Antipsychotic Agents Phase 4
29 Central Nervous System Depressants Phase 4
30 Hypoglycemic Agents Phase 4,Phase 2,Early Phase 1
31 Psychotropic Drugs Phase 4,Phase 2
32 Tranquilizing Agents Phase 4
33 Anticonvulsants Phase 4
34 Autonomic Agents Phase 4,Phase 2
35 Parasympatholytics Phase 4,Phase 2
36 Peripheral Nervous System Agents Phase 4,Phase 2
37 Anti-Asthmatic Agents Phase 4
38 Antioxidants Phase 4,Phase 2
39 Bronchodilator Agents Phase 4
40 Endothelium-Dependent Relaxing Factors Phase 4
41 Protective Agents Phase 4,Phase 2
42 Respiratory System Agents Phase 4
43 Hormone Antagonists Phase 4
44 Hormones Phase 4
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
46 Antibiotics, Antitubercular Phase 4
47 Anti-Inflammatory Agents Phase 4,Phase 2
48 Anti-HIV Agents Phase 4,Phase 2,Phase 1
49 Anti-Retroviral Agents Phase 4,Phase 2,Phase 1
50 Antiviral Agents Phase 4,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 65)

id Name Status NCT ID Phase Drugs
1 Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients Unknown status NCT02459288 Phase 4 Clopidogrel first;Ticagrelor first
2 Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients Completed NCT02644577 Phase 4 Metformin
3 Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) Completed NCT00934973 Phase 4 mebeverine;methylcellulose;placebo
4 Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide? Completed NCT02169596 Phase 4
5 Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? Completed NCT01298180 Phase 4 Growth hormone (Genotonorm® or Omnitrope®)
6 Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI Completed NCT02469740 Phase 4 Ticagrelor;Clopidogrel
7 Procalcitonin-Guided Antimicrobial Discontinuation Completed NCT00250666 Phase 4
8 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial) Recruiting NCT02193971 Phase 4 Prasugrel 5mg
9 Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease Recruiting NCT00982072 Phase 4 tacrolimus;prednisolone
10 Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG) Active, not recruiting NCT00843856 Phase 4 tacrolimus;tacrolimus and mycophenolate mofetil
11 Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection Not yet recruiting NCT03205566 Phase 4 Raltegravir 400Mg Tab;Lamivudine 150Mg Tablet
12 Clinical Trial Scheme of Shu Gan yi Yang Capsule Not yet recruiting NCT03290313 Phase 4 shu gan yi yang capsule;shu gan yi yang capsule simulation agent
13 Allopurinol in Acute Coronary Syndrome Terminated NCT01457820 Phase 4 Allopurinol;Allopurinol;Placebo
14 Probiotics for Portal Hypertension Unknown status NCT01134692 Phase 3 Propranolol, Norfloxacin, VSL#3
15 Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy Unknown status NCT00989508 Phase 2, Phase 3 Perhexiline;Placebo marked PEXSIG
16 Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions Completed NCT01532570 Phase 3 TA-650
17 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome Completed NCT00391872 Phase 3 Ticagrelor;Clopidogrel
18 Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery Completed NCT00845364 Phase 2, Phase 3 Perhexiline;Placebo marked PEXSIG
19 Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome Completed NCT00839228 Phase 2 Perhexiline;Placebo
20 The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. Completed NCT00405015 Phase 2 rosiglitazone
21 Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease Completed NCT00700297 Phase 2 Colchicine;Placebo
22 Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease Completed NCT00483184 Phase 2
23 Anakinra for Behcet s Disease Completed NCT01441076 Phase 1, Phase 2 Anakinra
24 A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease Completed NCT00866359 Phase 2 Apremilast (CC-10004);Placebo
25 A Clinical Study With MT-102 in Subjects With Cancer Cachexia Completed NCT01238107 Phase 2 MT-102
26 Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients Completed NCT00943540 Phase 2 raltegravir QD;atazanavir;lamivudine (or emtricitabine)
27 Effect of Vitamin E on Skin Aerobic Bacteria in Palmar Arsenical Keratosis Completed NCT02468518 Phase 2 Vitamin E capsule
28 A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation Recruiting NCT00794040 Phase 2 Citalopram;Methylphenidate
29 A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease Withdrawn NCT01211977 Phase 1, Phase 2 XOMA 052
30 Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children Completed NCT01982396 Phase 1 ABC Twice Daily;ABC Once Daily;3TC Once Daily;3TC Twice Daily
31 Ginsenoside Improve Metabolic Syndrome Unknown status NCT02034136
32 Meal Timing on Glucose and Hyperandrogenism in PCOS Women Unknown status NCT01711476
33 Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method Unknown status NCT00563615 Tegaserod
34 Accuracy Evaluation of the BD FACS Presto System Completed NCT02396355
35 Furocyst - Poly Cystic Ovary Syndrome Study Completed NCT02703064
36 A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China Completed NCT02600221
37 Psychological Symptoms in Patients With Behcet's Disease by SCL90-R Completed NCT00699985
38 Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder Completed NCT01282281
39 MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE Completed NCT01780363
40 The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome Completed NCT01418053 caraway oil;Olive oil
41 Menstrual Effects On Mood Symptoms in Bipolar Disorder Completed NCT00472615
42 Characterisation of Asthma in Obese Subjects Completed NCT00532831
43 The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease Completed NCT01720628
44 Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors Completed NCT00933296
45 Treatment to Enhance Cognition in Bipolar Disorder Completed NCT01470781
46 Behçet's Disease and Eosinophil Cationic Protein Completed NCT01584778
47 Texting to Improve Adherence in HIV+ With Bipolar Disorder Completed NCT02090634
48 RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders Completed NCT00080145 Risperidone
49 Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes Completed NCT01154543
50 Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders Recruiting NCT02456545

Search NIH Clinical Center for Bd Syndrome

Genetic Tests for Bd Syndrome

Anatomical Context for Bd Syndrome

MalaCards organs/tissues related to Bd Syndrome:

39
Endothelial, Liver, Heart, Ovary, Skin, Brain, Kidney

Publications for Bd Syndrome

Articles related to Bd Syndrome:

id Title Authors Year
1
Studies of malformation syndromes of man XXXVIII: The BD syndrome. A "new" multiple congenital anomalies/mental retardation syndrome with athetoid cerebral palsy. ( 1179793 )
1975

Variations for Bd Syndrome

Expression for Bd Syndrome

Search GEO for disease gene expression data for Bd Syndrome.

Pathways for Bd Syndrome

GO Terms for Bd Syndrome

Sources for Bd Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....